Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × Immunoenzyme Techniques × Clear all

NCT00544908 2015-10-05

Dasatinib in Treating Patients With Stage IV Pancreatic Cancer

Phase 2 Terminated

7 enrolled 4 charts

Gastrointestinal

Pancreatic Neoplasms